These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 22634722)
61. Do native and polymeric alpha1-antitrypsin activate human neutrophils in vitro? Persson C; Subramaniyam D; Stevens T; Janciauskiene S Chest; 2006 Jun; 129(6):1683-92. PubMed ID: 16778290 [TBL] [Abstract][Full Text] [Related]
62. Alpha 1-antitrypsin ameliorates ventilator-induced lung injury in rats by inhibiting inflammatory responses and apoptosis. Zhu H; He J; Liu J; Zhang X; Yang F; Liu P; Wang S Exp Biol Med (Maywood); 2018 Jan; 243(1):87-95. PubMed ID: 29096562 [TBL] [Abstract][Full Text] [Related]
63. Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin. Sosulski ML; Stiles KM; Frenk EZ; Hart FM; Matsumura Y; De BP; Kaminsky SM; Crystal RG JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759494 [TBL] [Abstract][Full Text] [Related]
64. Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin. Tumpara S; Gründing AR; Sivaraman K; Wrenger S; Olejnicka B; Welte T; Wurm MJ; Pino P; Kiseljak D; Wurm FM; Janciauskiene S Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360706 [TBL] [Abstract][Full Text] [Related]
65. Introducing standards of the best medical practice for patients with inherited alpha-1-antitrypsin deficiency in Central Eastern Europe. Valiulis A; Utkus A; Stukas R; Valiulis A; Siderius L; Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):107-14. PubMed ID: 24798601 [TBL] [Abstract][Full Text] [Related]
66. Increased outer arm and core fucose residues on the N-glycans of mutated alpha-1 antitrypsin protein from alpha-1 antitrypsin deficient individuals. McCarthy C; Saldova R; O'Brien ME; Bergin DA; Carroll TP; Keenan J; Meleady P; Henry M; Clynes M; Rudd PM; Reeves EP; McElvaney NG J Proteome Res; 2014 Feb; 13(2):596-605. PubMed ID: 24328305 [TBL] [Abstract][Full Text] [Related]
67. Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options? Modrykamien A; Stoller JK Expert Opin Pharmacother; 2009 Nov; 10(16):2653-61. PubMed ID: 19827990 [TBL] [Abstract][Full Text] [Related]
68. Therapeutic potential of alpha-1 antitrypsin in human disease. Kim M; Cai Q; Oh Y Ann Pediatr Endocrinol Metab; 2018 Sep; 23(3):131-135. PubMed ID: 30286568 [TBL] [Abstract][Full Text] [Related]
69. Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin. Stoller JK; Rouhani F; Brantly M; Shahin S; Dweik RA; Stocks JM; Clausen J; Campbell E; Norton F Chest; 2002 Jul; 122(1):66-74. PubMed ID: 12114340 [TBL] [Abstract][Full Text] [Related]
70. Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study. Agné A; Richter K; Tumpara S; Sauer AL; Beckert F; Wrenger S; Zakrzewicz A; Hecker A; Markmann M; Koch C; Zajonz T; Sander M; Böning A; Padberg W; Janciauskiene S; Grau V Int Immunopharmacol; 2020 Apr; 81():106297. PubMed ID: 32062078 [TBL] [Abstract][Full Text] [Related]
71. KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency. Devine AJ; Smith NJ; Joshi R; Brooks-Patton B; Dunham J; Varisco AN; Goodman EM; Fan Q; Zingarelli B; Varisco BM bioRxiv; 2024 May; ():. PubMed ID: 38766202 [TBL] [Abstract][Full Text] [Related]